Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 May 27;11(5):e049872.
doi: 10.1136/bmjopen-2021-049872.

Implementation of a complex intervention to improve hospital discharge: process evaluation of a cluster randomised controlled trial

Affiliations
Randomized Controlled Trial

Implementation of a complex intervention to improve hospital discharge: process evaluation of a cluster randomised controlled trial

Yael Rachamin et al. BMJ Open. .

Abstract

Objectives: To study the implementation of a cluster randomised controlled effectiveness-implementation hybrid trial testing the effectiveness of a medication review at hospital discharge combined with a communication stimulus between hospital physicians (HPs) and general practitioners (GPs) on rehospitalisation of multimorbid older patients.

Design: Extension of Grant's mixed method process evaluation framework to trials with multilevel clustering.

Setting: General internal medicine wards in Swiss hospitals.

Participants: Convenience samples of 15 chief physicians (of 21 hospitals participating in the effectiveness trial), 60 (74) senior HPs, 65 (164) junior HPs and 187 (411) GPs.

Implementation strategy: Two-hour teaching sessions for senior HPs on a patient-centred, checklist-guided discharge routine.

Process evaluation components: Data collection on recruitment, delivery and response from chief physicians (semistructured interviews), senior HPs, junior HPs, GPs (surveys) and patients (via HPs). Quantitative data were summarised using descriptive statistics, and interviews analysed using thematic analysis.

Outcome measures: Intervention dose (quantitative), implementation fidelity (qualitative), feasibility and acceptability, facilitators and barriers, implementation support strategies.

Results: Recruitment of hospitals was laborious but successful, with 21 hospitals recruited. Minimal workload and a perceived benefit for the clinic were crucial factors for participation. Intervention dose was high (95% of checklist activities carried out), but intervention fidelity was limited (discharge letters) or unknown (medication review). Recruitment and retention of patients was challenging, partly due to patient characteristics (old, frail) and the COVID-19 pandemic: Only 612 of the anticipated 2100 patients were recruited, and 31% were lost to follow-up within the first month after discharge. The intervention was deemed feasible and helpful by HPs, and the relevance of the topic appreciated by both HPs and GPs.

Conclusions: The results from this evaluation will support interpretation of the findings of the effectiveness study and may inform researchers and policy makers who aim at improving hospital discharge.

Trial registration number: ISRCTN18427377.

Keywords: general medicine (see internal medicine); public health; qualitative research; quality in health care.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Framework model for process (dark grey) and impact evaluation (light grey), adapted from Grant et al . cRCT, cluster randomised controlled trial; GP, general practitioner; HP, hospital physician.
Figure 2
Figure 2
Flow of hospitals, senior hospital physicians (HPs), junior HPs, general practitioners (GPs) and patients through the study, by study arm. Blue boxes illustrate data collection tools with number of responses [response rates].
Figure 3
Figure 3
Attitudes and perception of feasibility and usefulness of tools and procedures by junior and senior hospital physicians (HPs). Questions about general attitudes (A) were answered by HPs in both study arms (senior HPs: n = 44, junior HPs: n = 65); questions regarding checklist (B) and discharge summary (C) were only directed at the intervention group (senior HPs: n = 24, junior HPs: n = 38). The percentages given indicate (1) largely applies or applies, (2) partially applies, (3) does rather not or not apply.
Figure 4
Figure 4
General practitioners' (GPs) views on medication review and communication at hospital discharge. The percentages given indicate (1) largely applies or applies, (2) partially applies, (3) does rather not or not apply (GPs: n = 187). HP, hospital physicians.

References

    1. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014;13:57–65. 10.1517/14740338.2013.827660 - DOI - PMC - PubMed
    1. Calderón-Larrañaga A, Poblador-Plou B, González-Rubio F, et al. . Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract 2012;62:e821–6. 10.3399/bjgp12X659295 - DOI - PMC - PubMed
    1. Sganga F, Landi F, Ruggiero C, et al. . Polypharmacy and health outcomes among older adults discharged from Hospital: results from the crime study. Geriatr Gerontol Int 2015;15:141–6. 10.1111/ggi.12241 - DOI - PubMed
    1. Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 2005;31:4–11. 10.3928/0098-9134-20050901-04 - DOI - PubMed
    1. Nobili A, Licata G, Salerno F, et al. . Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol 2011;67:507–19. 10.1007/s00228-010-0977-0 - DOI - PubMed

Publication types

Associated data

LinkOut - more resources